U.S. nods Abbott's rapid COVID-19 test for at-home screenings in asymptomatic cases

Abbott Laboratories said on Wednesday that the U.S. Food and Drug Administration has greenlighted its rapid COVID-19 antigen test, which produces results in around 15 minutes, making it more readily available for regular screening at schools and workplaces.

The Illinois-based company announced on social media its BinaxNOW COVID-19 Self-Test has received U.S. FDA Emergency Use Authorization for asymptomatic, over-the-counter use, without prescription.

Search Trends